Advertisement

Extra-Virgin Olive Oil Improves Depression Symptoms Without Affecting Salivary Cortisol and Brain-Derived Neurotrophic Factor in Patients With Major Depression: A Double-Blind Randomized Controlled Trial

  • Sahar Foshati
    Affiliations
    Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
    Search for articles by this author
  • Ahmad Ghanizadeh
    Affiliations
    Department of Psychiatry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

    Department of Psychiatry, UCLA-Kern Psychiatry Residency Program, Kern Medical, CA
    Search for articles by this author
  • Masoumeh Akhlaghi
    Correspondence
    Address correspondence to: Masoumeh Akhlaghi, PhD, School of Nutrition and Food Sciences, Razi Blvd, Shiraz, Iran.
    Affiliations
    Department of Community Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
    Search for articles by this author
Published:August 03, 2021DOI:https://doi.org/10.1016/j.jand.2021.07.016

      Abstract

      Background

      Many patients with depression are reluctant to take psychiatric medications. Hence, complementary therapies such as nutritional considerations could be advantageous. The antidepressant potential of olive oil has been proved in observational studies.

      Objective

      The effect of extra-virgin olive oil (EVOO) on depression symptoms and cortisol and brain-derived neurotrophic factor (BDNF) levels in patients with depression was examined.

      Design and participants

      This was a double-blind randomized controlled trial conducted on 73 patients suffering from major depressive disorder in Shiraz, Iran, in 2016.

      Intervention

      The patients were randomly assigned to intervention (EVOO) and control (sunflower oil) groups and consumed 25 mL/d of the corresponding oil for 52 days.

      Main outcome measures

      Depression symptoms were assessed by Beck Depression Inventory-II (BDI-II) and 7-item Hamilton Depression Rating Scale (HAMD-7). Salivary cortisol levels were determined immediately after awakening and 30 minutes later. Cortisol awakening response and the area under the curve with respect to ground and increase were computed. Serum BDNF concentrations were also measured.

      Statistical analyses performed

      Statistical analysis was conducted based on intention-to-treat and per-protocol approaches. Within-group changes were examined with repeated measures (for BDI-II and HAMD-7) and with paired t test (for other variables). Between-group comparisons were performed with analysis of covariance after adjustment for confounding factors.

      Results

      In intention-to-treat analysis, HAMD-7 score was the only variable with significant changes within and between groups, the latter as a greater decline in EVOO group (P = .001). BDI-II score did not show significant change in either group but the between-group comparison revealed a significant difference (P = .021). EVOO showed antidepressant effect in severely depressed patients (P = .017 for BDI-II and 0.008 for HAMD-7) but not in mild/moderate depression category. Serum BDNF concentrations, salivary cortisol levels at immediately after awakening (T0) and 30 minutes later, cortisol awakening response, the area under the curve with respect to ground and increase did not change within or between groups. Results of per-protocol analysis were not different.

      Conclusions

      The results of this study suggested beneficial effects of EVOO on depression symptoms in patients with severe depression but not in those with mild to moderate depression. The effects were significant from both statistical and clinical points of view.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Academy of Nutrition and Dietetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • World Health Organization
        Depression.
        (Updated January 30, 2020)
        • GBD 2017 Disease and Injury Incidence and Prevalence Collaborators
        Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017.
        Lancet. 2018; 392: 1789-1858https://doi.org/10.1016/S0140-6736(18)32279-7
        • Kennedy N.
        • Abbott R.
        • Paykel E.S.
        Remission and recurrence of depression in the maintenance era: Long-term outcome in a Cambridge cohort.
        Psychol Med. 2003; 33: 827-838https://doi.org/10.1017/s003329170300744x
        • Wang Y.X.
        • Xiang Y.T.
        • Su Y.A.
        • et al.
        Antipsychotic medications in major depression and the association with treatment satisfaction and quality of life: Findings of three national surveys on use of psychotropics in China between 2002 and 2012.
        Chin Med J (Engl). 2015; 128: 1847-1852https://doi.org/10.4103/0366-6999.160485
        • Kupfer D.J.
        • Charney D.S.
        Difficult-to-treat depression.
        Biol Psychiatry. 2003; 53: 633-634https://doi.org/10.1016/s0006-3223(03)00188-4
        • Tolkien K.
        • Bradburn S.
        • Murgatroyd C.
        An anti-inflammatory diet as a potential intervention for depressive disorders: A systematic review and meta-analysis.
        Clin Nutr. 2019; 38: 2045-2052https://doi.org/10.1016/j.clnu.2018.11.007
        • Parletta N.
        • Zarnowiecki D.
        • Cho J.
        • et al.
        A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: A randomized controlled trial (HELFIMED).
        Nutr Neurosci. 2019; 22: 474-487https://doi.org/10.1080/1028415X.2017.1411320
        • Huang Q.
        • Liu H.
        • Suzuki K.
        • Ma S.
        • Liu C.
        Linking what we eat to our mood: A review of diet, dietary antioxidants, and depression.
        Antioxidants (Basel). 2019; 8 (pii: E376. https://doi.org/10.3390/antiox8090376): 376
        • Perveen T.
        • Hashmi B.M.
        • Haider S.
        • Tabassum S.
        • Saleem S.
        • Siddiqui M.A.
        Role of monoaminergic system in the etiology of olive oil induced antidepressant and anxiolytic effects in rats.
        ISRN Pharmacol. 2013; 2013: 615685https://doi.org/10.1155/2013/615685
        • Pitozzi V.
        • Jacomelli M.
        • Zaid M.
        • et al.
        Effects of dietary extra-virgin olive oil on behaviour and brain biochemical parameters in ageing rats.
        Br J Nutr. 2010; 103: 1674-1683https://doi.org/10.1017/S0007114509993655
        • Pagliai G.
        • Sofi F.
        • Vannetti F.
        • et al.
        Mediterranean diet, food consumption and risk of late-life depression: The Mugello Study.
        J Nutr Health Aging. 2018; 22: 569-574https://doi.org/10.1007/s12603-018-1019-3
        • Vermeulen E.
        • Stronks K.
        • Visser M.
        • et al.
        The association between dietary patterns derived by reduced rank regression and depressive symptoms over time: The Invecchiare in Chianti (InCHIANTI) study.
        Br J Nutr. 2016; 115: 2145-2153https://doi.org/10.1017/S0007114516001318
        • Sánchez-Villegas A.
        • Verberne L.
        • De Irala J.
        • et al.
        Dietary fat intake and the risk of depression: The SUN Project.
        PLoS One. 2011; 6: e16268https://doi.org/10.1371/journal.pone.0016268
        • Psaltopoulou T.
        • Sergentanis T.N.
        • Panagiotakos D.B.
        • Sergentanis I.N.
        • Kosti R.
        • Scarmeas N.
        Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis.
        Ann Neurol. 2013; 74: 580-591https://doi.org/10.1002/ana.23944
        • Canheta A.B.S.
        • Santos A.S.E.A.C.
        • Souza J.D.
        • Silveira E.A.
        Traditional Brazilian diet and extra virgin olive oil reduce symptoms of anxiety and depression in individuals with severe obesity: Randomized clinical trial.
        Clin Nutr. 2021; 40 (pii: S0261-5614(20)30283-30281): 404-411
        • Godos J.
        • Castellano S.
        • Ray S.
        • Grosso G.
        • Galvano F.
        Dietary polyphenol intake and depression: Results from the Mediterranean Healthy Eating, Lifestyle and Aging (MEAL) Study.
        Molecules. 2018; 23: 999https://doi.org/10.3390/molecules23050999
        • Lai J.S.
        • Oldmeadow C.
        • Hure A.J.
        • McEvoy M.
        • Hiles S.A.
        • Boyle M.
        • Attia J.
        Inflammation mediates the association between fatty acid intake and depression in older men and women.
        Nutr Res. 2016; 36: 234-245https://doi.org/10.1016/j.nutres.2015.11.017
        • Herbert J.
        Cortisol and depression: Three questions for psychiatry.
        Psychol Med. 2013; 43: 449-469https://doi.org/10.1017/S0033291712000955
        • Dedovic K.
        • Ngiam J.
        The cortisol awakening response and major depression: Examining the evidence.
        Neuropsychiatr Dis Treat. 2015; 11: 1181-1189https://doi.org/10.2147/NDT.S62289
        • Hernández M.E.
        • Mendieta D.
        • Martínez-Fong D.
        • et al.
        Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder.
        Eur Neuropsychopharmacol. 2008; 18: 917-924https://doi.org/10.1016/j.euroneuro.2008.08.001
        • Yang T.
        • Nie Z.
        • Shu H.
        • et al.
        The role of BDNF on neural plasticity in depression.
        Front Cell Neurosci. 2020; 14: 82https://doi.org/10.3389/fncel.2020.00082
        • Beck A.T.
        • Steer R.A.
        • Garbin M.G.
        Psychometric properties of the Beck Depression Inventory. Twenty-five years of evaluation.
        Clin Psychol Rev. 1998; 8: 77-100https://doi.org/10.1016/0272-7358(88)90050-5
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        5th ed. 2013 (American Psychiatric Publishing)
        • Martínez-González M.A.
        • García-Arellano A.
        • Toledo E.
        • et al.
        A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: The PREDIMED trial.
        PLoS One. 2012; 7e43134https://doi.org/10.1371/journal.pone.0043134
        • Grenyer B.F.
        • Crowe T.
        • Meyer B.
        • et al.
        Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo-controlled trial.
        Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31: 1393-1396https://doi.org/10.1016/j.pnpbp.2007.06.004
        • Silvers K.M.
        • Woolley C.C.
        • Hamilton F.C.
        • Watts P.M.
        • Watson R.A.
        Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression.
        Prostaglandins Leukot Essent Fatty Acids. 2005; 72: 211-218https://doi.org/10.1016/j.plefa.2004.11.004
        • Carrasco-Pancorbo A.
        • Cerretani L.
        • Bendini A.
        • Segura-Carretero A.
        • Lercker G.
        • Fernández-Gutiérrez A.
        Evaluation of the influence of thermal oxidation on the phenolic composition and on the antioxidant activity of extra-virgin olive oils.
        J Agric Food Chem. 2007; 55: 4771-4780https://doi.org/10.1021/jf070186m
        • Trumbo P.
        • Schlicker S.
        • Yates A.A.
        • Poos M.
        Food and Nutrition Board of the Institute of Medicine. The National Academies. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.
        J Am Diet Assoc. 2002; 102: 1621-1630https://doi.org/10.1016/s0002-8223(02)90346-9
        • U.S. Department of Health and Human Services and U.S. Department of Agriculture
        2015–2020 Dietary Guidelines for Americans. 8th ed.
        (Published December 2015)
        • McIntyre R.S.
        • Konarski J.Z.
        • Mancini D.A.
        • et al.
        Measuring the severity of depression and remission in primary care: Validation of the HAMD-7 scale.
        CMAJ. 2005; 173: 1327-1334https://doi.org/10.1503/cmaj.050786
        • Tunn S.
        • Möllmann H.
        • Barth J.
        • Derendorf H.
        • Krieg M.
        Simultaneous measurement of cortisol in serum and saliva after different forms of cortisol administration.
        Clin Chem. 1992; 38: 1491-1494
        • Kirschbaum C.
        • Hellhammer D.H.
        Salivary cortisol in psychoneuroendocrine research: Recent developments and applications.
        Psychoneuroendocrinology. 1994; 19: 313-333
        • Saxbe D.E.
        A field (researcher’s) guide to cortisol: tracking HPA axis functioning in everyday life.
        Health Psychol Rev. 2008; 2: 163-190https://doi.org/10.1080/17437190802530812
        • Amlashi F.G.
        • Swearingen B.
        • Faje A.T.
        • et al.
        Accuracy of late-night salivary cortisol in evaluating postoperative remission and recurrence in Cushing’s disease.
        J Clin Endocrinol Metab. 2015; 100: 3770-3777https://doi.org/10.1210/jc.2015-2107
        • Pruessner J.C.
        • Kirschbaum C.
        • Meinlschmid G.
        • Hellhammer D.H.
        Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change.
        Psychoneuroendocrinology. 2003; 28: 916-931https://doi.org/10.1016/s0306-4530(02)00108-7
        • Fekedulegn D.B.
        • Andrew M.E.
        • Burchfiel C.M.
        • et al.
        Area under the curve and other summary indicators of repeated waking cortisol measurements.
        Psychosom Med. 2007; 69: 651-659https://doi.org/10.1097/PSY.0b013e31814c405c
      1. N-Squared Computing (Firm). Nutritionist IV: Diet Analysis. Version 3.5.2. Salem. Released 1994.

        • Moghaddam M.H.B.
        • Aghdam F.B.
        • Jafarabadi M.A.
        • Allahverdipour H.
        • Nikookheslat S.D.
        • Safarpour S.
        The Iranian Version of International Physical Activity Questionnaire (IPAQ) in Iran: Content and construct validity, factor structure, internal consistency and stability.
        World Appl Sci. 2012; 18: 1073-1080
        • Farrahi Moghaddam J.
        • Nakhaee N.
        • Sheibani V.
        • Garrusi B.
        • Amirkafi A.
        Reliability and validity of the Persian version of the Pittsburgh Sleep Quality Index (PSQI-P).
        Sleep Breath. 2012; 16: 79-82https://doi.org/10.1007/s11325-010-0478-5
      2. IBM SPSS Statistics for Windows. Version 22.0. Armonk, NY: IBM Corp. Released 2013.

        • Liao J.M.
        • Stack C.B.
        Annals understanding clinical research: Implications of missing data due to dropout.
        Ann Intern Med. 2017; 166: 596-598https://doi.org/10.7326/M17-0195
        • Nakagawa S.
        • Cuthill I.C.
        Effect size, confidence interval and statistical significance: A practical guide for biologists.
        Biol Rev Camb Philos Soc. 2007; 82: 591-605https://doi.org/10.1111/j.1469-185X.2007.00027.x
        • Rogers P.J.
        • Appleton K.M.
        • Kessler D.
        • et al.
        No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: A randomised controlled trial.
        Br J Nutr. 2008; 99: 421-431https://doi.org/10.1017/S0007114507801097
        • Liao Y.
        • Xie B.
        • Zhang H.
        • et al.
        Efficacy of omega-3 PUFAs in depression: A meta-analysis.
        Transl Psychiatry. 2019; 9: 190https://doi.org/10.1038/s41398-019-0515-5
        • Bae J.H.
        • Kim G.
        Systematic review and meta-analysis of omega-3-fatty acids in elderly patients with depression.
        Nutr Res. 2018; 50: 1-9https://doi.org/10.1016/j.nutres.2017.10.013
        • Yang J.R.
        • Han D.
        • Qiao Z.X.
        • Tian X.
        • Qi D.
        • Qiu X.H.
        Combined application of eicosapentaenoic acid and docosahexaenoic acid on depression in women: A meta-analysis of double-blind randomized controlled trials.
        Neuropsychiatr Dis Treat. 2015; 11: 2055-2061https://doi.org/10.2147/NDT.S86581
        • Sublette M.E.
        • Ellis S.P.
        • Geant A.L.
        • Mann J.J.
        Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.
        J Clin Psychiatry. 2011; 72: 1577-1584https://doi.org/10.4088/JCP.10m06634
        • Logan A.C.
        Omega-3 and depression research: Hold the olive oil.
        Prostaglandins Leukot Essent Fatty Acids. 2005; 72: 441
        • Terés S.
        • Barceló-Coblijn G.
        • Benet M.
        • et al.
        Oleic acid content is responsible for the reduction in blood pressure induced by olive oil.
        Proc Natl Acad Sci U S A. 2008; 105: 13811-13816https://doi.org/10.1073/pnas.0807500105
        • Alberts G.L.
        • Chio C.L.
        • Im W.B.
        Allosteric modulation of the human 5-HT(7A) receptor by lipidic amphipathic compounds.
        Mol Pharmacol. 2001; 60: 1349-1355
        • Mueller G.P.1
        • Driscoll W.J.
        Biosynthesis of oleamide.
        Vitam Horm. 2009; 81: 55-78https://doi.org/10.1016/S0083-6729(09)81003-0
        • Ge L.
        • Zhu M.M.
        • Yang J.Y.
        • et al.
        Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression.
        Pharmacol Biochem Behav. 2015; 131: 77-86https://doi.org/10.1016/j.pbb.2015.01.017
        • Ricciutelli M.
        • Marconi S.
        • Boarelli M.C.
        • et al.
        Olive oil polyphenols: A quantitative method by high-performance liquid-chromatography-diode-array detection for their determination and the assessment of the related health claim.
        J Chromatogr A. 2017; 1481: 53-63https://doi.org/10.1016/j.chroma.2016.12.020
        • Bayes J.
        • Schloss J.
        • Sibbritt D.
        Effects of polyphenols in a Mediterranean diet on symptoms of depression: A systematic literature review.
        Adv Nutr. 2020; 11: 602-615https://doi.org/10.1093/advances/nmz117
        • Bhatt S.
        • Nagappa A.N.
        • Patil C.R.
        Role of oxidative stress in depression.
        Drug Discov Today. 2020; 25: 1270-1276https://doi.org/10.1016/j.drudis.2020.05.001
        • Friedman E.S.
        • Davis L.L.
        • Zisook S.
        • et al.
        Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial.
        Eur Neuropsychopharmacol. 2012; 22: 183-199https://doi.org/10.1016/j.euroneuro.2011.07.010
        • Henkel V.
        • Seemüller F.
        • Obermeier M.
        • et al.
        Relationship between baseline severity of depression and antidepressant treatment outcome.
        Pharmacopsychiatry. 2011; 44: 27-32https://doi.org/10.1055/s-0030-1267177
        • Blom M.B.
        • Spinhoven P.
        • Hoffman T.
        • et al.
        Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression.
        J Affect Disord. 2007; 104: 119-1126
        • Joensuu M.
        • Ahola P.
        • Knekt P.
        • et al.
        Baseline symptom severity predicts serotonin transporter change during psychotherapy in patients with major depression.
        Psychiatry Clin Neurosci. 2016; 70: 34-41https://doi.org/10.1111/pcn.12335
        • Edwards B.C.
        • Lambert M.J.
        • Moran P.W.
        • McCully T.
        • Smith K.C.
        • Ellingson A.G.
        A meta-analytic comparison of the Beck Depression Inventory and the Hamilton Rating Scale for Depression as measures of treatment outcome.
        Br J Clin Psychol. 1984; 23: 93-99https://doi.org/10.1111/j.2044-8260.1984.tb00632.x
        • Schneibel R.
        • Brakemeier E.L.
        • Wilbertz G.
        • Dykierek P.
        • Zobel I.
        • Schramm E.
        Sensitivity to detect change and the correlation of clinical factors with the Hamilton Depression Rating Scale and the Beck Depression Inventory in depressed inpatients.
        Psychiatry Res. 2012; 198: 62-67https://doi.org/10.1016/j.psychres.2011.11.014
        • Enns M.W.
        • Larsen D.K.
        • Cox B.J.
        Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables.
        J Affect Disord. 2000; 60: 33-41https://doi.org/10.1016/s0165-0327(99)00156-1
        • Bartels M.
        • Van den Berg M.
        • Sluyter F.
        • Boomsma D.I.
        • de Geus E.J.
        Heritability of cortisol levels: Review and simultaneous analysis of twin studies.
        Psychoneuroendocrinology. 2003; 28: 121-137https://doi.org/10.1016/s0306-4530(02)00003-3
        • Juruena M.F.
        • Bocharova M.
        • Agustini B.
        • Young A.H.
        Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
        J Affect Disord. 2018; 233: 45-67https://doi.org/10.1016/j.jad.2017.09.052
        • Rothe N.
        • Steffen J.
        • Penz M.
        • Kirschbaum C.
        • Walther A.
        Examination of peripheral basal and reactive cortisol levels in major depressive disorder and the burnout syndrome: A systematic review.
        Neurosci Biobehav Rev. 2020; 114: 232-270https://doi.org/10.1016/j.neubiorev.2020.02.024
        • Nandam L.S.
        • Brazel M.
        • Zhou M.
        • Jhaveri D.J.
        Cortisol and major depressive disorder-translating findings from humans to animal models and back.
        Front Psychiatry. 2020; 10: 974https://doi.org/10.3389/fpsyt.2019.00974
        • Keller J.
        • Gomez R.
        • Williams G.
        • et al.
        HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
        Mol Psychiatry. 2017; 22: 527-536https://doi.org/10.1038/mp.2016.120
        • Deuschle M.
        • Hamann B.
        • Meichel C.
        • et al.
        Antidepressive treatment with amitriptyline and paroxetine: Effects on saliva cortisol concentrations.
        J Clin Psychopharmacol. 2003; 23: 201-205https://doi.org/10.1097/00004714-200304000-00014
        • Cohrs S.
        • Röher C.
        • Jordan W.
        • et al.
        The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.
        Psychopharmacology (Berl). 2006; 185: 11-18https://doi.org/10.1007/s00213-005-0279-x
        • Sarubin N.
        • Nothdurfter C.
        • Schmotz C.
        • et al.
        Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression.
        Psychoneuroendocrinology. 2014; 39: 141-151https://doi.org/10.1016/j.psyneuen.2013.10.008
        • Yosaee S.
        • Soltani S.
        • Esteghamati A.
        • et al.
        Effects of zinc, vitamin D, and their co-supplementation on mood, serum cortisol, and brain-derived neurotrophic factor in patients with obesity and mild to moderate depressive symptoms: A phase II, 12-wk, 2 × 2 factorial design, double-blind, randomized, placebo-controlled trial.
        Nutrition. 2020; 71: 110601https://doi.org/10.1016/j.nut.2019.110601
        • Gerber M.
        • Imboden C.
        • Beck J.
        • et al.
        Effects of aerobic exercise on cortisol stress reactivity in response to the trier social stress test in inpatients with major depressive disorders: A randomized controlled trial.
        J Clin Med. 2020; 9: 1419https://doi.org/10.3390/jcm9051419
        • Sánchez-Villegas A.
        • Galbete C.
        • Martinez-González M.A.
        • et al.
        The effect of the Mediterranean diet on plasma brain-derived neurotrophic factor (BDNF) levels: The PREDIMED-NAVARRA randomized trial.
        Nutr Neurosci. 2011; 14: 195-201https://doi.org/10.1179/1476830511Y.0000000011
        • Groves J.O.
        Is it time to reassess the BDNF hypothesis of depression?.
        Mol Psychiatry. 2007; 12: 1079-1088
        • Molendijk M.L.
        • Spinhoven P.
        • Polak M.
        • Bus B.A.
        • Penninx B.W.
        • Elzinga B.M.
        Serum BDNF concentrations as peripheral manifestations of depression: Evidence from a systematic review and meta-analyses on 179 associations (N=9484).
        Mol Psychiatry. 2014; 19: 791-800https://doi.org/10.1038/mp.2013.105
        • Dwivedi Y.
        Brain-derived neurotrophic factor: role in depression and suicide.
        Neuropsychiatr Dis Treat. 2009; 5: 433-449https://doi.org/10.2147/ndt.s5700
        • Racagni G.
        • Popoli M.
        Cellular and molecular mechanisms in the long-term action of antidepressants.
        Dialogues Clin Neurosci. 2008; 10: 385-400https://doi.org/10.31887/DCNS.2008.10.4/gracagni
        • Thomas E.A.
        • Carson M.J.
        • Neal M.J.
        • Sutcliffe J.G.
        Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide.
        Proc Natl Acad Sci U S A. 1997; 94: 14115-14119https://doi.org/10.1073/pnas.94.25.14115
        • Maya-López M.
        • Rubio-López L.C.
        • Rodríguez-Alvarez I.V.
        • et al.
        A cannabinoid receptor-mediated mechanism participates in the neuroprotective effects of oleamide against excitotoxic damage in rat brain synaptosomes and cortical slices.
        Neurotox Res. 2020; 37: 126-135https://doi.org/10.1007/s12640-019-00083-1

      Biography

      S. Foshati is a PhD student, Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

      Biography

      A. Ghanizadeh is an associate professor of nutrition, Department of Psychiatry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, and the Department of Psychiatry, UCLA-Kern Psychiatry Residency Program, Kern Medical, CA.

      Biography

      M. Akhlaghi is a professor, Department of Community Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

      Linked Article